表紙:吸引式ドラッグデリバリー装置:医療機器のパイプライン評価
市場調査レポート
商品コード
851182

吸引式ドラッグデリバリー装置:医療機器のパイプライン評価

Inhalable Drug Delivery Devices - Medical Devices Pipeline Product Landscape, 2021

出版日: | 発行: GlobalData | ページ情報: 英文 156 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=114.86円
吸引式ドラッグデリバリー装置:医療機器のパイプライン評価
出版日: 2021年12月07日
発行: GlobalData
ページ情報: 英文 156 Pages
納期: 即納可能 即納可能とは
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、世界の吸引式ドラッグデリバリー (薬剤送達) 装置の市場における、主要なパイプライン製品 (医療機器) とその治験の進行状況について調査すると共に、製品の機能・特性の比較分析 (治験の進行段階別) や、主要企業のプロファイルおよび代表的製品、昨今の市場動静 (業績報告・資本取引動向など) といった情報を取りまとめてお届けいたします。

第1章 目次

第2章 イントロダクション

  • 吸引式ドラッグデリバリー装置の概要

第3章 治験中の製品

  • パイプライン製品:治験段階別
  • パイプライン製品:分野別
  • パイプライン製品:地域別
  • パイプライン製品:規制経路別
  • パイプライン製品:推定認証時期別
  • 現在進行中の治験

第4章 治験中のパイプライン製品:企業別

  • 吸引式ドラッグデリバリー装置の企業:治験段階別のパイプライン製品
  • 吸引式ドラッグデリバリー装置:治験段階別のパイプライン製品

第5章 吸引式ドラッグデリバリー装置市場:企業・製品の概要

  • Acorda Therapeutics Inc
  • Baxter International Inc
  • Bellerophon Therapeutics Inc
  • Breath Therapeutics Holding BV
  • Canigma A.L LTD
  • Edixomed Ltd
  • iDTx Systems, Inc.
  • Impel NeuroPharma Inc
  • Kanabo Research Ltd
  • Mallinckrodt Plc
  • Medical Developments International Ltd
  • Medspray BV
  • NeuroproteXeon Inc
  • Next Safety, Inc.
  • Nobilis Therapeutics Inc
  • Sandoz International GmbH
  • Texas Tech University Health Sciences Center
  • University of Texas Health Science Center at Houston
  • Vectura Group Plc
  • Vero Biotech LLC
  • VitalMIST
  • Windtree Therapeutics Inc

第6章 吸引式ドラッグデリバリー装置市場:昨今の動向 (全10件)

第7章 付録

図表

List of Tables

Inhalable Drug Delivery Devices - Pipeline Products by Stage of Development

Inhalable Drug Delivery Devices - Pipeline Products by Segment

Inhalable Drug Delivery Devices - Pipeline Products by Territory

Inhalable Drug Delivery Devices - Pipeline Products by Regulatory Path

Inhalable Drug Delivery Devices - Pipeline Products by Estimated Approval Date

Inhalable Drug Delivery Devices - Ongoing Clinical Trials

Inhalable Drug Delivery Companies - Pipeline Products by Stage of Development

Inhalable Drug Delivery Devices - Pipeline Products by Stage of Development

Glossary

List of Figures

Inhalable Drug Delivery Devices - Pipeline Products by Stage of Development

Inhalable Drug Delivery Devices - Pipeline Products by Segment

Inhalable Drug Delivery Devices - Pipeline Products by Territory

Inhalable Drug Delivery Devices - Pipeline Products by Regulatory Path

Inhalable Drug Delivery Devices - Pipeline Products by Estimated Approval Date

Inhalable Drug Delivery Devices - Ongoing Clinical Trials

目次
Product Code: GDME1296EPD

GlobalData's Medical Devices sector report, "Inhalable Drug Delivery Devices - Medical Devices Pipeline Product Landscape, 2021" provides comprehensive information about the Inhalable Drug Delivery Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Inhalable Drug Delivery device is meant to administer medications that are to be inhaled deeply into the lungs.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Inhalable Drug Delivery Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Inhalable Drug Delivery Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Inhalable Drug Delivery Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Introduction

  • 2.1 Inhalable Drug Delivery Devices Overview

3 Products under Development

  • 3.1 Inhalable Drug Delivery Devices - Pipeline Products by Stage of Development
  • 3.2 Inhalable Drug Delivery Devices - Pipeline Products by Segment
  • 3.3 Inhalable Drug Delivery Devices - Pipeline Products by Territory
  • 3.4 Inhalable Drug Delivery Devices - Pipeline Products by Regulatory Path
  • 3.5 Inhalable Drug Delivery Devices - Pipeline Products by Estimated Approval Date
  • 3.6 Inhalable Drug Delivery Devices - Ongoing Clinical Trials

4 Inhalable Drug Delivery Devices - Pipeline Products under Development by Companies

  • 4.1 Inhalable Drug Delivery Companies - Pipeline Products by Stage of Development
  • 4.2 Inhalable Drug Delivery Devices - Pipeline Products by Stage of Development

5 Inhalable Drug Delivery Companies and Product Overview

  • 5.1 Acorda Therapeutics Inc Company Overview
  • 5.2 Actervis GmbH Company Overview
  • 5.3 Aerami Therapeutics Inc Company Overview
  • 5.4 Aerophase Inc Company Overview
  • 5.5 Alexza Pharmaceuticals Inc Company Overview
  • 5.6 Atossa Therapeutics Inc Company Overview
  • 5.7 Baxter International Inc Company Overview
  • 5.8 Bellerophon Therapeutics Inc Company Overview
  • 5.9 Breath Therapeutics Holding BV Company Overview
  • 5.10 California Northstate University College of Medicine Company Overview
  • 5.11 Canigma A.L LTD Company Overview
  • 5.12 Edixomed Ltd Company Overview
  • 5.13 Engage Therapeutics Inc Company Overview
  • 5.14 iDTx Systems, Inc. Company Overview
  • 5.15 Impel NeuroPharma Inc Company Overview
  • 5.16 Inhalation Sciences Sweden AB Company Overview
  • 5.17 InhaleRx Ltd Company Overview
  • 5.18 Invero Pharma LLC Company Overview
  • 5.19 Jupiter Research LLC Company Overview
  • 5.20 Kanabo Research Ltd Company Overview
  • 5.21 Mallinckrodt Plc Company Overview
  • 5.22 Medical Developments International Ltd Company Overview
  • 5.23 Medspray BV Company Overview
  • 5.24 Monash University Company Overview
  • 5.25 Nemera La Verpilliere Company Overview
  • 5.26 Next Safety, Inc. Company Overview
  • 5.27 Nobilis Therapeutics Inc Company Overview
  • 5.28 OncoSec Medical Inc Company Overview
  • 5.29 Parnell Pharmaceuticals Inc Company Overview
  • 5.30 Pharmosa Biopharm Inc Company Overview
  • 5.31 Rhinomed Limited Company Overview
  • 5.32 Rutgers Cancer Institute of New Jersey Company Overview
  • 5.33 Sandoz International GmbH Company Overview
  • 5.34 Seng Vital International GmbH Company Overview
  • 5.35 Shenzhen Smoore Technology Ltd Company Overview
  • 5.36 Technology Commercialization Partners LLC Company Overview
  • 5.37 Tetra Bio-Pharma Inc Company Overview
  • 5.38 Teva Pharmaceutical Industries Ltd Company Overview
  • 5.39 Texas Tech University Health Sciences Center Company Overview
  • 5.40 Third Pole Inc Company Overview
  • 5.41 Tiziana Life Sciences PLC Company Overview
  • 5.42 Torrent Pharmaceuticals Ltd Company Overview
  • 5.43 University Hospital Southampton NHS Foundation Trust Company Overview
  • 5.44 University of Texas Health Science Center at Houston Company Overview
  • 5.45 Vectura Group Plc Company Overview
  • 5.46 Veoli Ltd Company Overview
  • 5.47 Vero Biotech LLC Company Overview
  • 5.48 Via Therapeutics LLC Company Overview
  • 5.49 Virpax Pharmaceuticals Inc Company Overview
  • 5.50 VistaGen Therapeutics Inc Company Overview
  • 5.51 VitalMIST Company Overview
  • 5.52 Windtree Therapeutics Inc Company Overview

6 Inhalable Drug Delivery- Recent Developments

7 Appendix

  • 7.1 Methodology
  • 7.2 About GlobalData
  • 7.3 Contact Us
  • 7.4 Disclaimer